LifeMD (LFMD) Net Cash Flow (2012 - 2025)

LifeMD has reported Net Cash Flow for 14 years, with the latest figure at -$3.4 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow rose 40.23% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$14.0 million (down 262.88% YoY), and the FY2025 full-year result was -$14.6 million, down 1033.83% from the prior year.
• Net Cash Flow for Q4 2025 stood at -$3.4 million, up from -$12.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $31.9 million in Q4 2021, with the low at -$16.2 million in Q1 2022.
• Historically, Net Cash Flow has averaged $401525.4 across 5 years, with a median of $487090.5 in 2023.
• The largest YoY upside for Net Cash Flow was 18546.01% in 2021 against a maximum downside of 1472.52% in 2021.
• LifeMD's Net Cash Flow stood at $31.9 million in 2021, then tumbled by 105.89% to -$1.9 million in 2022, then surged by 1050.99% to $17.9 million in 2023, then sank by 132.1% to -$5.7 million in 2024, then soared by 40.23% to -$3.4 million in 2025.
• The last three Net Cash Flow figures came in at -$3.4 million (Q4 2025), -$12.4 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.